MedTrace Logo

Effects of Growth Hormone on the Nitric Oxide Pathway

NCT00470002 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2007-05-07

No results posted yet for this study

Summary

The purpose of the study is to determine whether the treatment with growth hormone has an influence on the nitric oxide pathway in healthy males.

Conditions

Interventions

DRUG

Somatropin

Sponsors & Collaborators

  • Pharmacia

    collaborator INDUSTRY

  • Hannover Medical School

    lead OTHER

Principal Investigators

  • Dirk O Stichtenoth, MD · Institute of Clinical Pharmacology, Hannover Medical School

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2004-05-31
Completion
2005-01-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00470002 on ClinicalTrials.gov